91 related articles for article (PubMed ID: 1439090)
1. [The influence of a new beta agonist: formoterol on mucociliary function].
Melloni B; Germouty J
Rev Mal Respir; 1992; 9(5):503-7. PubMed ID: 1439090
[TBL] [Abstract][Full Text] [Related]
2. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
Aziz I; Hall IP; McFarlane LC; Lipworth BJ
J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
[TBL] [Abstract][Full Text] [Related]
3. Effect of inhalation of salbutamol, beclomethasone dipropionate & ipratropium bromide on mucociliary clearance in some patients with chronic stable bronchial asthma.
Guleria R; Singh TR; Sinha S; Padhy AK; Gupta K; Pande JN
Indian J Med Res; 2003 Apr; 117():158-63. PubMed ID: 14604304
[TBL] [Abstract][Full Text] [Related]
4. [Changes in specific airway resistance after powder inhalation of formoterol or salmeterol in moderate bronchial asthma].
Sill V; Bartuschka B; Villiger B; Ortland C; Domej W
Pneumologie; 1999 Jan; 53(1):4-9. PubMed ID: 10091511
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of formoterol and salbutamol on bronchial hyperreactivity and beta-adrenoceptor density on lymphocytes in children with bronchial asthma.
Kozlik-Feldmann R; von Berg A; Berdel D; Reinhardt D
Eur J Med Res; 1996 Jul; 1(10):465-70. PubMed ID: 9438143
[TBL] [Abstract][Full Text] [Related]
6. Effects of formoterol and tiotropium bromide on mucus clearance in patients with COPD.
Meyer T; Reitmeir P; Brand P; Herpich C; Sommerer K; Schulze A; Scheuch G; Newman S
Respir Med; 2011 Jun; 105(6):900-6. PubMed ID: 21397483
[TBL] [Abstract][Full Text] [Related]
7. The effects of formoterol, a long-acting beta 2-adrenoceptor agonist, on mucociliary activity.
Lindberg S; Khan R; Runer T
Eur J Pharmacol; 1995 Oct; 285(3):275-80. PubMed ID: 8575514
[TBL] [Abstract][Full Text] [Related]
8. [Effect of the long-acting beta-2 agonist inhalant formoterol on the quality of sleep of patients with bronchial asthma].
Konermann M; Lück G; Rawert B; Pirsig W
Pneumologie; 2000 Mar; 54(3):104-9. PubMed ID: 10783649
[TBL] [Abstract][Full Text] [Related]
9. Inhalation devices for long-acting beta2-agonists: efficiency and ease of use of dry powder formoterol inhalers for use by patients with asthma and COPD.
Molimard M; Till D; Stenglein S; Singh D; Krummen M
Curr Med Res Opin; 2007 Oct; 23(10):2405-13. PubMed ID: 20350055
[TBL] [Abstract][Full Text] [Related]
10. Hexoprenaline--a new bronchodilator.
Vermaak JC; De Kock MA; Joubert JR
S Afr Med J; 1972 Dec; 46(51):1999-2001. PubMed ID: 4651880
[No Abstract] [Full Text] [Related]
11. Effect of formoterol with or without budesonide in repeated low-dose allergen challenge.
Dahlén B; Lantz AS; Ihre E; Skedinger M; Henriksson E; Jörgensen L; Ekström T; Dahlén SE; Larsson K
Eur Respir J; 2009 Apr; 33(4):747-53. PubMed ID: 19129280
[TBL] [Abstract][Full Text] [Related]
12. Effect of aerosolized uridine 5'-triphosphate on mucociliary clearance in mild chronic bronchitis.
Bennett WD; Zeman KL; Foy C; Shaffer CL; Johnson FL; Regnis JA; Sannuti A; Johnson J
Am J Respir Crit Care Med; 2001 Jul; 164(2):302-6. PubMed ID: 11463605
[TBL] [Abstract][Full Text] [Related]
13. A comparison of pressure-packed bornchodilator aerosols in chronic obstructive bronchitis.
Chatterjee SS; Dinda P; Riding WD
Scand J Respir Dis; 1971; 52(2):71-6. PubMed ID: 5170643
[No Abstract] [Full Text] [Related]
14. [Long-term effect of the beta 2-sympathomimetic formoterol in young smokers--study of duration and site of effect of bronchodilatation using conventional methods of lung function and monodispersed aerosols].
Siekmeier R; Schiller-Scotland CF; Stahlhofen W; Kronenberger H
Pneumologie; 1994 Apr; 48(4):225-30. PubMed ID: 7914366
[TBL] [Abstract][Full Text] [Related]
15. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial.
Bölükbas S; Eberlein M; Eckhoff J; Schirren J
Eur J Cardiothorac Surg; 2011 Jun; 39(6):995-1000. PubMed ID: 20970351
[TBL] [Abstract][Full Text] [Related]
16. Does a beta 2-stimulator really facilitate mucociliary transport in the human lungs in vivo? A study with procaterol.
Isawa T; Teshima T; Hirano T; Anazawa Y; Miki M; Konno K; Motomiya M
Am Rev Respir Dis; 1990 Mar; 141(3):715-20. PubMed ID: 1968734
[TBL] [Abstract][Full Text] [Related]
17. [The effect of a single dose of formoterol using an aerosol inhaler in asthmatic children. A randomized, controlled, double-blind study].
Lebecque P; Vliers S; De Saint-Moulin T; Godding V
Rev Mal Respir; 1994; 11(1):47-50. PubMed ID: 7907426
[TBL] [Abstract][Full Text] [Related]
18. [Nebuliser delivery of berodual in patients with bronchial asthma and chronic obstructive bronchitis].
Iakushin SS; Smirnova EA
Klin Med (Mosk); 1999; 77(7):49. PubMed ID: 10483167
[No Abstract] [Full Text] [Related]
19. Inhaled adrenergics and anticholinergics in obstructive lung disease: do they enhance mucociliary clearance?
Restrepo RD
Respir Care; 2007 Sep; 52(9):1159-73; discussion 1173-5. PubMed ID: 17716384
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, double-dummy, single-dose, crossover trial evaluating the efficacy and safety profiles of two dose levels (12 and 24 microg) of formoterol-HFA (pMDI) vs. those of a dose level (24 microg) of formoterol-DPI (Foradil/Aerolizer) and of placebo (pMDI or Aerolizer) in moderate to severe asthmatic patients.
Bousquet J; Guenolé E; Duvauchelle T; Vicaut E; Lefrançois G
Respiration; 2005; 72 Suppl 1():13-9. PubMed ID: 15915008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
